Adaptive phenotype drives resistance to androgen deprivation therapy in prostate cancer

BACKGROUND: Prostate cancer (PCa), the second most common cancer affecting men worldwide, shows a broad spectrum of biological and clinical behaviour representing the epiphenomenon of an extreme heterogeneity. Androgen deprivation therapy is the mainstay of treatment for advanced forms but after few...

Full description

Saved in:

Bibliographic Details
Published in:	Cell Commun Signal
Main Authors:	Ferrari, Nicoletta, Granata, Ilaria, Capaia, Matteo, Piccirillo, Marina, Guarracino, Mario Rosario, Venè, Roberta, Brizzolara, Antonella, Petretto, Andrea, Inglese, Elvira, Morini, Martina, Astigiano, Simonetta, Amaro, Adriana Agnese, Boccardo, Francesco, Balbi, Cecilia, Barboro, Paola
Format:	Artigo
Language:	Inglês
Published:	BioMed Central 2017
Subjects:	Research
Online Access:	https://ncbi.nlm.nih.gov/pmc/articles/PMC5721601/ https://ncbi.nlm.nih.gov/pubmed/29216878 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12964-017-0206-x
Tags:	Add Tag No Tags, Be the first to tag this record!

Adaptive phenotype drives resistance to androgen deprivation therapy in prostate cancer

Similar Items